TEL AVIV, Israel and SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) — Biolojic Design, a biotechnology company that uses AI to transform antibodies into intelligent medicinal solutions, today announced that Nektar exercised its license option to develop a program resulting from the companies’ research collaboration initiated in 2021.
Read more here.
![[Classiq in The New Stack] Classiq brings abstraction layer to quantum software stack](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
